GENEVA, Dec. 28 -- ZHEJIANG TERUISI PHARMACEUTICAL INC. (No.799 Huanshan Road, Longxi Street, Huzhou South Taihu New DistrictHuzhou, Zhejiang 313005), 浙江特瑞思药业股份有限公司 (中国浙江省湖州市湖州南太湖新区龙溪街道环山路799号) filed a patent application (PCT/CN2025/101011) for "PHARMACEUTICAL COMBINATION COMPRISING ANTI-CD20 ANTIBODY-DRUG CONJUGATE AND USE THEREOF FOR TREATING NON-HODGKIN LYMPHOMA" on Jun 13, 2025. With publication no. WO/2025/261276, the details related to the patent application was published on Dec 26, 2025...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.